Radient Pharmaceuticals Corporation fka RXPC

[guardiangel]

Radient Restructured By A Planned Reverse Merger

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=116668271


LOU....They can't show any proof that the IP and Trademarks were transferred from AMDL Diagnostics Inc to some company in Australia that does not exist. They need to look at the agreement and understand contractual law..In the transfers of Onko-Sure and DR-70, it states that the assignor(Radient Pharmaceuticals) owns 100 per cent of the assignee stock(AMDL Diagnostics Inc.) Here is the Proof and Facts do matter you understand...It is found in Section B of the transfer agreement.....What the people here are stating is that because the CEO's of AMDL Diagnostics and Radient are aussies and they have a alleged corporation in Australia they now own 100 per cent of the Radient and AMDL Diagnostics Stock..That is absurd ....That is like saying when Mac was CEO of Radient he could start a corporation and take all of RAdienta nd AMDL Diagnostics assets and stock and transfer it to his EWELLNESS corporation..Too funny on this board...

http://assignments.uspto.gov/assignments/assignment-tm-5580-0634.pdf

http://assignments.uspto.gov/assignments/assignment-tm-5580-0640.pdf





Lou You Said:


Re: Radient Restructured By A Planned Reverse Merger

I find it amusing that the ****** automatically assume the worst outcome for any situation- it shows a complete lack of credibility. Since Bill White has been appointed CEO by Dougie Mac to be the public face of AMDL Dx, the ******* spread the rumor that he has "taken over and transferred" all Radient properties to CST AMDL. The ******* insist that the trademarks are no longer with AMDL Dx.

As said before, they conveniently overlook the fact that Mac and Akio are still President and Treasurer respectively. All three are working in unison to bring the Reverse Merger to fruition.

Question: have you any additional info on the CST AMDL website. Is Charter the "out of control renegade" CEO that is trying to strip Radient of all its properties? Or just trying to set up his business in preparation for the merger.

$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$


Re: Radient Restructured By A Planned Reverse Merger

Radient owns 100 per cent of the AMDL Diagnostics Inc. Stock as the Transfer of Trademarks stated...The aussies are just CEO's that is all..We the shareholders have control of radient and AMDL Diagnostics not the Aussies...

In late 2014 , Uni wanted to get exclusive rights to the production and Distribution of Dr-70 other than Taiwan..In the agreement between Radient/AMDL Diagnostics Inc. back in 2013 it only gave Uni exclusive rights to distribute in Taiwan..They did have rights in the other territories as stated in the agreement in June 2013..

Also there was a new agreement drawn up before the Trademarks were transferred from radient to AMDL Diagnostics Inc..This is mentioned below in the Uni-Pharma news from their web site and the insider information or is it insighter information we are gathering you understand..

Here is the statement from Uni and the OLD agreement...In the transfer it ststed that Radient did not give rights for any other entity to use the Onko-Sure and Dr-70 trademarks..This would not be a true statement if the old agreement was still in effect, so the new agreement between Uni and AMDL Diagnostics Inc. was completed before December 21, 2014 before the signing and transfer of the two Registered Trademarks...By the way..The Attorney for Radient resigned, you know the same attorney that resigned back in 2014 after the smoke screen patent was let go.


THis is from the Uni-Pharma News section from February 2015..
Get Onko-Sure DR-70 tumor markers domestic production license by the end of 2014


2015/02/26

The company has made at the end of 2014 Onko-Sure DR-70 tumor markers domestic production license, and earlier this year the domestic sales of the exhibition ? business plans within three years to complete the major countries in Asia-Pacific (Japan, Korea, Australia, New Zealand, ASEAN countries, China to Turkey and more than twenty countries) of the market, taken the domestic market into the regional market and even the size of the global market.
Arima drugs combined number of expert consultants and research units, using the latest technology to Onko-Sure DR-70 continuous improvement, it is desirable to develop a second generation of rapid screening products or more precisely the Bead Assay products, but also about Arima binding Onko-Sure the third generation of research reagents Sure combo with other tumor markers, the future will have the exclusive patent protection for these products are made and exclusive.

NOW UNI_PHARMA HAS EXCLUSIVE RIGHTS TO MANUFACTURE AN DISTRIBUTE ONKO_SURE AND DR 70 TO ALL OVER THE WORLD FOR THREE MORE YEARS>>>THEY APPEAR TO WANT TO TAKE OVER RADIENT AND AMDL DIAGNOSICS INC> IF THEY WANT TO GO BEYOND 3 MORE YEARS ON THEIR CURRENT AGREEMENT WITH AMDL DIAGNOSTICS INC.,OR THEY WILL HAVE TO NEGOTIATE A NEW AGREEMENT AT THAT TIME FROM PROVISTA DIGNOSTICS ACCORDING TO THE @)!) LOI TO REVERSE MERGE WITH RADIENT.

http://uni-pharma.com/news_overview.html


$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

From the 8-K in June 2013 and the agreement between Radient and AMDL Diagnostics Inc. and Uni-Pharma

Whereas, UNI wishes to hold a non-exclusive 5 year license (excepting Taiwan which remains exclusive per UNI-RXPC exclusive distribution agreement) to RXPC’s Onko-Sure and DR-70 cancer blood test kits (the “Tests”), procedures, analyses, data, know how, manufacturing, manufacturing processes, components, trademarks and intellectual property identified in Exhibit A (the “Intellectual Property”).

http://www.sec.gov/Archives/edgar/data/838879/000121390013003078/f8k061113ex10i_radientpharm.htm